Home > Insider Trading > Filing (0001104659-14-001755)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1544227	Ovascience Inc.	OVAS	Pharmaceutical Preparations (2834)	451472564

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551614	Michelle Dipp	C/O Ovascience, Inc., 215 First Street, Suite 240 Cambridge MA 02142	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-23	300	$9.10	814,557	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,720,571	Indirect	By Longwood Fund, LP

Footnotes

The Form 4 filed on December 26, 2013 correctly stated the Reporting Person's holdings and is being amended solely to file the Power of Attorney pursuant to which the initial Form 4 was filed. This filing does not otherwise amend such filing.
The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
Represents 702,627 shares of common stock and 111,930 RSUs.
Longwood Fund GP, LLC is the general partner of Longwood Fund, L.P. Voting and investment power with respect to the shares held by Longwood Fund, LP are vested in Richard Aldrich, Michelle Dipp, M.D., Ph.D. and Christoph Westphal, M.D., Ph.D. (collectively, the "Managers"), the managers of Longwood Fund GP, LLC. Each of the Managers disclaims beneficial ownership of the shares held by Longwood Fund, L.P., except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in the report shall not be deemed an admission of beneficial ownership of the shares for the purposes of Section 16 or for any other purpose.